Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

June 30, 2014

Conditions
Osteoarthritis, KneeArthritis of KneeKnee Osteoarthritis
Interventions
OTHER

Allogenic mesenchymal stromal cells injection

Mesenchymal stem cells prepared from bone marrow of healthy donors and expanded for 3-4 weeks according to our procedure described in PEI Num. 10-134, authorized by the Spanish Medicine Agency

DRUG

Hyaluronic Acid

Intra-articular injection of 60 mg of hyaluronic acid (Durolane) in a single injection (3 ml)

Trial Locations (2)

47003

Hospital Clinico Universitario, Valladolid

08022

Centro Medico Teknon, Barcelona

All Listed Sponsors
collaborator

University of Valladolid

OTHER

collaborator

Sanidad de Castilla y León

OTHER

collaborator

Centro Medico Teknon

OTHER

lead

Red de Terapia Celular

INDUSTRY

NCT01586312 - Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells | Biotech Hunter | Biotech Hunter